Delivery Order SPE2DR25D3010-SPE2DR26F88HD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets (500-count packages) with a ceiling value of $4,774.04. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $7,103.78 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.45 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 8 MEQ tablets (500-count packaging). This competitively awarded, firm fixed-price delivery order was issued on December 16, 2025, with an ultimate completion date of December 17, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This contract represents a child order under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.58 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a routine pharmaceutical procurement from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500 units, with a contract ceiling value of approximately $8,000. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 21, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for potassium chloride extended-release 10 milliequivalent tablets (1,000 count) under a firm fixed price contract valued at $9,269.60, with an ultimate completion date of December 22, 2025. This non-set-aside, competitively awarded delivery order represents a specific pharmaceutical product procurement from the vendor's existing indefinite delivery contract (IDC) with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $3,997.19 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ capsules (500-count units). This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 100 units, with a contract ceiling value of $2,303.04. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency has awarded a delivery order valued at $5,935.34 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride ER 8 MEQ tablets in quantities of 500 units. This is a firm fixed-price delivery order with no set-aside designation, awarded on June 9, 2025, with an ultimate completion date of June 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,639.37 on August 14, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500. This firm fixed-price, competitively awarded contract is scheduled for ultimate completion on August 15, 2025, with performance conducted at the vendor's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating the award was made through...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88HDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 10 MEQ tablets (1,000 count) valued at $2,253.96. This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of December 22, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract under the company's broader pharmaceutical supply framework with the federal government. This award falls under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for the company's comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to fulfill federal pharmaceutical procurement requirements efficiently and reliably.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/18/25 |